Abstract:Purpose: The number of people with type 2 diabetes (T2D) is growing rapidly worldwide. Islet beta-cell dysfunction and failure are the main causes of T2D pathological processes. The aim of this study was to elucidate the underlying pathways and coexpression networks in T2D islets. Materials and methods: We analyzed the differentially expressed genes (DEGs) in the data set GSE41762, which contained 57 nondiabetic and 20 diabetic samples, and developed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Protein-protein interaction (PPI) network, the modules from the PPI network, and the gene annotation enrichment of modules were analyzed as well. Moreover, a weighted correlation network analysis (WGCNA) was applied to screen critical gene modules and coexpression networks and explore the biological significance. Results: We filtered 957 DEGs in T2D islets. Then GO and KEGG analyses identified that key pathways like inflammatory response, type B pancreatic cell differentiation, and calcium ion-dependent exocytosis were involved in human T2D. Three significant modules were filtered from the PPI network. Ribosome biogenesis, extrinsic apoptotic signaling pathway, and membrane depolarization during action potential were associated with the modules, respectively. Furthermore, coexpression network analysis by WGCNA identified 13 distinct gene modules of T2D islets and revealed four modules, which were strongly correlated with T2D and T2D biomarker hemoglobin A1c (HbA1c). Functional annotation showed that these modules mainly enriched KEGG pathways such as NV-kappa B signaling pathway, tumor necrosis factor signaling pathway, cyclic adenosine monophosphate signaling pathway, and peroxisome proliferators-activated receptor signaling pathway. Conclusion: The results provide potential gene pathways and underlying molecular mechanisms for the prevention, diagnosis, and treatment of T2D.

PROGRESS OF STUDIES ON THE RELATIONSHIP BETWEEN UNCOUPLING PROTEIN-2 AND TYPE 2 DIABETES MELLITUS

PROGRESS OF STUDIES ON THE RELATIONSHIP BETWEEN UNCOUPLING PROTEIN-2 AND TYPE 2 DIABETES MELLITUS

Association Between the Polymorphism of Urotensin II Gene and the Onset of Diabetic Nephropathy in Chinese Subjects

Research of Uncoupling Protein 2

Uncoupling Protein and Nonalcoholic Fatty Liver Disease.

Nuclear Family Study of the Relationship Between Uncoupling Protein 2 Gene -866G/A Polymorphism and Type 2 Diabetes Mellitus and Related Traits

Uncoupling Protein 2 and Peroxisome Proliferator-Activated Receptor γ Gene Polymorphisms in Association with Diabetes Susceptibility in Chinese Han Population with Variant Glucose Tolerance

Relationship Between Uncoupling Protein 2 Gene Promoter-866 G/A Polymorphism and Chinese Diabetic Nephropathy

Uncoupling Protein 2 as a Pathogenic Determinant and Therapeutic Target in Cardiovascular and Metabolic Diseases

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

UCP2–866G/A Polymorphism is Associated with Prediabetes and Type 2 Diabetes

Uncoupling Protein-2 Negatively Regulates Insulin Secretion and is a Major Link Between Obesity, Β Cell Dysfunction, and Type 2 Diabetes

Polymorphisms in the Uncoupling Protein 2 Gene Are Associated with Diabetic Retinopathy in Han Chinese Patients with Type 2 Diabetes.

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Research Progress of the Relationships Between Gene Variations in Chromosome Region 1Q21-Q25 and Type 2 Diabetes Mellitns

UCP2 and UCP3 Variants and Gene-Environment Interaction Associated with Prediabetes and T2DM in a Rural Population: a Case Control Study in China

Relationship of the Expression of Uncoupling Protein 2 with Oxidative Stress and Insulin Resistance in High-Fat-fed Rats

Molecular Classification and Individual Treatment of Type 2 Diabetes Mellitus

[An Association Study of Abdominal Obesity and Polymorphisms of UCP2 and SREBP1c Genes].

Exploring the design of clinical research studies on the efficacy mechanisms in type 2 diabetes mellitus

Progress in Metabonomics of Type 2 Diabetes Mellitus